|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.89 PKR | +0.85% |
|
-1.97% | +34.33% |
Citi Pharma Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was PKR 12,396.98 million compared to PKR 9,779.88 million a year ago. Net income was PKR 657.98 million compared to PKR 653.69 million a year ago.
Basic earnings per share from continuing operations was PKR 2.88 compared to PKR 2.88 a year ago. Diluted earnings per share from continuing operations was PKR 2.88 compared to PKR 2.88 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +34.33% | 25.96M | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
CITI PHARMA LIMITED 
